316 related articles for article (PubMed ID: 32305313)
1. Erdheim-Chester disease.
Starkebaum G; Hendrie P
Best Pract Res Clin Rheumatol; 2020 Aug; 34(4):101510. PubMed ID: 32305313
[TBL] [Abstract][Full Text] [Related]
2. The histiocytosis Erdheim-Chester disease is an inflammatory myeloid neoplasm.
Haroche J; Cohen-Aubart F; Charlotte F; Maksud P; Grenier PA; Cluzel P; Mathian A; Emile JF; Amoura Z
Expert Rev Clin Immunol; 2015; 11(9):1033-42. PubMed ID: 26197238
[TBL] [Abstract][Full Text] [Related]
3. BRAF V600E mutation in Juvenile Xanthogranuloma family neoplasms of the central nervous system (CNS-JXG): a revised diagnostic algorithm to include pediatric Erdheim-Chester disease.
Picarsic J; Pysher T; Zhou H; Fluchel M; Pettit T; Whitehead M; Surrey LF; Harding B; Goldstein G; Fellig Y; Weintraub M; Mobley BC; Sharples PM; Sulis ML; Diamond EL; Jaffe R; Shekdar K; Santi M
Acta Neuropathol Commun; 2019 Nov; 7(1):168. PubMed ID: 31685033
[TBL] [Abstract][Full Text] [Related]
4. Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era.
Goyal G; Heaney ML; Collin M; Cohen-Aubart F; Vaglio A; Durham BH; Hershkovitz-Rokah O; Girschikofsky M; Jacobsen ED; Toyama K; Goodman AM; Hendrie P; Cao XX; Estrada-Veras JI; Shpilberg O; Abdo A; Kurokawa M; Dagna L; McClain KL; Mazor RD; Picarsic J; Janku F; Go RS; Haroche J; Diamond EL
Blood; 2020 May; 135(22):1929-1945. PubMed ID: 32187362
[TBL] [Abstract][Full Text] [Related]
5. Erdheim-Chester disease with bilateral orbital masses and multi-systemic symptoms: two case reports.
Qiao J; Ma R; Peng X; He W
World J Surg Oncol; 2023 Jul; 21(1):233. PubMed ID: 37525276
[TBL] [Abstract][Full Text] [Related]
6. Dabrafenib and steroids for the treatment of Erdheim-Chester disease with extensive CNS involvement: a case report.
Yuen CA; Bao S; Aung MS; Shishodia R; Kong XT
Per Med; 2024; 21(2):71-78. PubMed ID: 38275171
[TBL] [Abstract][Full Text] [Related]
7. Advances in Understanding and Management of Erdheim-Chester Disease.
Kulkarni AM; Gayam PKR; Aranjani JM
Life Sci; 2024 Jul; 348():122692. PubMed ID: 38710283
[TBL] [Abstract][Full Text] [Related]
8. [Erdheim-Chester disease-A histiocytic multisystem disease with unusual renal involvement].
Dasdelen S; Büschek F
Internist (Berl); 2020 Sep; 61(9):969-979. PubMed ID: 32785740
[TBL] [Abstract][Full Text] [Related]
9. Erdheim-Chester disease: a comprehensive review from the ophthalmologic perspective.
Kanakis M; Petrou P; Lourida G; Georgalas I
Surv Ophthalmol; 2022; 67(2):388-410. PubMed ID: 34081930
[TBL] [Abstract][Full Text] [Related]
10. Erdheim Chester disease in a patient with Burkitt lymphoma: a case report and review of literature.
Sakr HI; Buckley K; Baiocchi R; Zhao WJ; Hemminger JA
Diagn Pathol; 2018 Nov; 13(1):94. PubMed ID: 30474563
[TBL] [Abstract][Full Text] [Related]
11. Erdheim-Chester Disease: Comprehensive Review of Molecular Profiling and Therapeutic Advances.
Haroun F; Millado K; Tabbara I
Anticancer Res; 2017 Jun; 37(6):2777-2783. PubMed ID: 28551613
[TBL] [Abstract][Full Text] [Related]
12. Erdheim-Chester Disease with BRAF V600E Mutation and a Concomitant Myeloid Malignancy Sharing NRAS and IDH2 Mutations.
Prabhakaran N; Jour G; Balar A; Ward N
Acta Haematol; 2023; 146(3):245-251. PubMed ID: 36754028
[TBL] [Abstract][Full Text] [Related]
13. Erdheim-Chester disease involving the breast--a rare but important differential diagnosis.
Guo S; Yan Q; Rohr J; Wang Y; Fan L; Wang Z
Hum Pathol; 2015 Jan; 46(1):159-64. PubMed ID: 25454479
[TBL] [Abstract][Full Text] [Related]
14. Erdheim-Chester disease.
Campochiaro C; Tomelleri A; Cavalli G; Berti A; Dagna L
Eur J Intern Med; 2015 May; 26(4):223-9. PubMed ID: 25865950
[TBL] [Abstract][Full Text] [Related]
15. Erdheim-Chester Disease: a Concise Review.
Papo M; Emile JF; Maciel TT; Bay P; Baber A; Hermine O; Amoura Z; Haroche J
Curr Rheumatol Rep; 2019 Dec; 21(12):66. PubMed ID: 31807955
[TBL] [Abstract][Full Text] [Related]
16. Hypoalphalipoproteinemia and BRAF
Cohen-Aubart F; Guerin M; Poupel L; Cluzel P; Saint-Charles F; Charlotte F; Arsafi Y; Emile JF; Frisdal E; Le Goff C; Donadieu J; Amoura Z; Lesnik P; Haroche J; Le Goff W
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1913-1925. PubMed ID: 29930009
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults.
Milne P; Bigley V; Bacon CM; Néel A; McGovern N; Bomken S; Haniffa M; Diamond EL; Durham BH; Visser J; Hunt D; Gunawardena H; Macheta M; McClain KL; Allen C; Abdel-Wahab O; Collin M
Blood; 2017 Jul; 130(2):167-175. PubMed ID: 28512190
[TBL] [Abstract][Full Text] [Related]
18. Neurologic and oncologic features of Erdheim-Chester disease: a 30-patient series.
Bhatia A; Hatzoglou V; Ulaner G; Rampal R; Hyman DM; Abdel-Wahab O; Durham BH; Dogan A; Ozkaya N; Yabe M; Petrova-Drus K; Panageas KS; Reiner A; Rosenblum M; Diamond EL
Neuro Oncol; 2020 Jul; 22(7):979-992. PubMed ID: 31950179
[TBL] [Abstract][Full Text] [Related]
19. [Use of targeting therapy in Erdheim-Chester disease: A case report with neurologic involvement].
Berthe P; Rouzic N; Daelman L; Jacobzone C; Espitia A; Cohen-Aubart F; Haroche J; Émile JF; Lorleac'h A
Rev Med Interne; 2020 Jun; 41(6):413-417. PubMed ID: 32113636
[TBL] [Abstract][Full Text] [Related]
20. Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Destombes-Rosai-Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders.
Papo M; Cohen-Aubart F; Trefond L; Bauvois A; Amoura Z; Emile JF; Haroche J
Curr Oncol Rep; 2019 May; 21(7):62. PubMed ID: 31115724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
